Windtree Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -24 | -21 | -22 | |
EBITDA | -2,811 | -11,693 | 10,367 | -5,120 |
EBIT | -2,938 | -11,717 | 10,346 | -5,142 |
Net Income | -2,749 | -12,024 | 10,219 | -5,154 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,444 | -2,338 | -2,947 | -3,567 |
Cash | 2,300 | 1,803 | 2,547 | 4,319 |
Basic Shares | 887 | 575 | 470 | 300 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -82 | -1,061 | -869 | -638 |
EBITDA | -20,159 | -39,461 | -76,640 | -31,803 |
EBIT | -20,241 | -40,522 | -77,509 | -32,441 |
Net Income | -20,291 | -39,208 | -67,636 | -30,280 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -5,648 | |||
Free Cash Flow | -13,452 | -19,465 | -23,943 | -25,606 |
Cash | 4,319 | 6,172 | 22,348 | 16,930 |
Basic Shares | 220 | 40 | 30 | 20 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$4.22 |
2024-06-30 | -$20.91 |
2024-03-31 | -$0.74 |
2023-12-31 | -$0.74 |
